| 10419-0 | Transfuse factor VIII | BLDBK |
| 104190-4 | Mucopolysaccharidosis type II comment Narrative (Dbs) | CHEM |
| 104191-2 | Guanidinoacetate methyltransferase (GAMT) deficiency newborn screening panel | PANEL.CHEM |
| 104192-0 | Guanidinoacetate methyltransferase deficiency newborn screen interpretation | CHEM |
| 104193-8 | Guanidinoacetate methyltransferase deficiency comment Narrative (Dbs) | CHEM |
| 104194-6 | Creatine (Dbs) | CHEM |
| 104195-3 | Guanidinoacetate/Creatinine (Dbs) | CHEM |
| 104196-1 | Creatine/Creatinine (Dbs) | CHEM |
| 104197-9 | Ultrasound for pregnancy in first trimester Mother | OBGYN |
| 104198-7 | Immunoglobulin lambda light chain gene 22q11.22 rearrangement in Specimen (fish) | MOLPATH.REARRANGE |
| 104199-5 | Immunoglobulin kappa light chain gene 2p11.2 rearrangement in Specimen (fish) | MOLPATH.REARRANGE |
| 1042-1 | H Ab from Blood product unit (qualitative) | BLDBK |
| 10420-8 | Transfuse immune serum globulin | BLDBK |
| 104200-1 | CRLF2 gene rearrangements or Marrow (Blood, fish) | MOLPATH.REARRANGE |
| 104201-9 | Eszopiclone and Zopiclone (Urine, lc/ms/ms) | DRUG/TOX |
| 104202-7 | Active medication list Episode Pharmacy | HL7.SMP |
| 104203-5 | Reconciled medication list Episode Pharmacy | HL7.SMP |
| 104204-3 | Discharged medication list Episode Pharmacy | HL7.SMP |
| 104205-0 | Patient generated medication list Episode Pharmacy | HL7.SMP |
| 104206-8 | Private medication list Episode Pharmacy | HL7.SMP |
| 104207-6 | Medication administration list Episode Pharmacy | HL7.SMP |
| 104208-4 | Medication list for public health AndOr CDC reporting Episode Pharmacy | HL7.SMP |
| 104209-2 | Transfer medication list Episode Pharmacy | HL7.SMP |
| 10421-6 | Transfuse Pentaspan | BLDBK |
| 104210-0 | Diagnostic multisection transesophageal and cardioversion panel Heart | PANEL.CARDIAC |
| 104211-8 | Heart Multisection transesophageal for congenital disease Document (us --w agitated saline iv) | CARD.US |
| 104212-6 | Views screening for diabetic retinopathy of Eyes | H&P.PX |
| 104213-4 | Views screening for diabetic retinopathy of Left eye | H&P.PX |
| 104214-2 | Views screening for diabetic retinopathy of Right eye | H&P.PX |
| 104215-9 | MG stereo Breast - left Views post radioactive seed localization | RAD |
| 104216-7 | MG stereo Breast - right Views post radioactive seed localization | RAD |
| 104217-5 | Additional treatment (Urine) | FERT |
| 104218-3 | Spermatozoa Nonprogressive/Spermatozoa --post ejaculation (Urine) | FERT |
| 104219-1 | Spermatozoa Immotile/Spermatozoa --post ejaculation (Urine) | FERT |
| 10422-4 | Transfuse plasma | BLDBK |
| 104220-9 | Spermatozoa Viable/Spermatozoa --post ejaculation (Urine) | FERT |
| 104221-7 | Spermatozoa.progressive.rapid/Spermatozoa --post ejaculation (Urine) | FERT |
| 104222-5 | Spermatozoa.progressive.slow/Spermatozoa --post ejaculation (Urine) | FERT |
| 104223-3 | Spermatozoa.progressive.slow+rapid/Spermatozoa --post ejaculation (Urine) | FERT |
| 104224-1 | HLA-DPB1+DPA1 Typing panel - Blood or Tissue from Donor | PANEL.HLA |
| 104225-8 | HLA-DPB1+DPA1 Typing panel - Blood or Tissue | PANEL.HLA |
| 104226-6 | Duration of condition per episode - Reported (qualitative) | H&P.HX |
| 104227-4 | Rizatriptan (Urine, confirmatory method) | DRUG/TOX |
| 104228-2 | Alpha-Pyrrolidinoisohexanophenone (Urine, confirmatory method) | DRUG/TOX |
| 104229-0 | Carfentanil (Urine, confirmatory method) | DRUG/TOX |
| 10423-2 | Transfuse platelets | BLDBK |
| 104230-8 | MDMB-Fubinaca (Urine, confirmatory method) | DRUG/TOX |
| 104231-6 | N-Ethylpentylone (Urine, confirmatory method) | DRUG/TOX |
| 104232-4 | Naproxen (Urine, confirmatory method) | DRUG/TOX |
| 104233-2 | Norcocaine (Urine, confirmatory method) | DRUG/TOX |